Nutrition and age-related ocular disease

Current Topics in Nutraceutical Research

Volumn 3, Issue 4, 2005, Pages 231-242

  Bartlett, Hannah ^a   Eperjesi, Frank ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Age related macular degeneration; Antioxidant; Cataract; Glaucoma; Lutein; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BUPHENINE; CYANOCOBALAMIN; GINKGO BILOBA EXTRACT; LYCOPENE; PLACEBO; REACTIVE OXYGEN METABOLITE; RETINOL; RIBOFLAVIN; VISALINE; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN; ZINC SULFATE;

CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; GLAUCOMA; HUMAN; IN VITRO STUDY; INTRAOCULAR PRESSURE; LIPID PEROXIDATION; MEDLINE; META ANALYSIS; MONOTHERAPY; PHOTORECEPTOR MEMBRANE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VITAMIN BLOOD LEVEL;

GINKGO BILOBA;

EID: 32044472292     PISSN: 15407535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Bartlett, H. and Eperjesi, F. (2003). Age-related macular degeneration and nutritional supplementation: a review of randomised controlled trials. Ophthalmic and Physiological Optics. 23, 383-399.
2. Beatty, S., Koh, H. H., Henson, D. and Boulton, M. (2000). The role of oxidative stress in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology. 45, 115-134.
3. Belda, J., Roma, J., Vilela, C., Puertas, F., Diaz-Llopis, M., Bosch-Morell, F. and Romero, F. (1999). Serum vitamin E levels negatively correlate with severity of age-related macular degeneration. Mechanisms of ageing and development. 107, 159-164.
4. Bennett, D. (2004). Nutrition and glaucoma: do supplements reduce IOP? Optometry Today. May 7, 32-39.
5. Berendschot, T., Goldbohm, R. A., Klopping, W. A. A., van de Kraats, J., van Norel, J. and van Norren, D. (2000). Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Investigative Ophthalmology & Visual Science. 41, 3322-3326.
6. Bird, A. E. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., Dejong, P., Klaver, C. C. W., Klein, B. E. K., Klein, R., Mitchell, P., Sarks, J. P., Sarks, S. H., Sourbane, G., Taylor, H. R. and Vingerling, J. R. (1995). An International Classification and Grading System for Age-Related Maculopathy and Age-Related Macular Degeneration. Survey of Ophthalmology. 39, 367-374.
7. Blumenkranz, M. S., Russell, S. R., Robey, M. G., Kottblumenkranz, R. and Penneys, N. (1986). Risk-Factors in Age-Related Maculopathy Complicated by Choroidal Neovascularization. Ophthalmology. 93, 552-558.
8. Bone, R., Landrum, J., Friedes, L., Gomez, C., Kilburn, M., Menendez, E., Vidal, I. and Wang, W. (1997). Distribution of lutein and zeaxanthin stereoisomers in the human retina. Experimental Eye Research. 64, 211-218.
9. Bone, R., Landrum, J. and Tarsis, S. (1985). Preliminary identification of the human macular pigment. Vision Research. 25, 1531-1535.
10. Bone, R., Landrum, J. T. and Fernandez, L. (1988). Analysis of the macular pigment by HPLC: retinal distribution and age study. Investigative Ophthalmological Vision Science. 29, 843-849.
11. Borish, E., Prior, W. and Venuugopal, S. (1987). DNA synthesis is blocked by cigarette tar-induced DNA single strand breaks. Carcinogenesis. 8, 1517-1520.
12. Brown, L., Rimm, E., Seddon, J., EL, G., Chasan-Taber, I., Spiegelman, D., Willett, W. and Hansinson, S. (1999). A prospective study of carotenoid intake and risk of cataract extraction in US men. American Journal of Clinical Nutrition. 70, 517-524.
13. Cardinale, G., Dreyfus, P., Auld, P. and Abeles, R. (1969). Experimental vitamin B12 deficiency: its effect on tissue vitamin B12-coenzyme levels and on the metabolism of methylmalonyl-CoA. Archives of Biochemistry and Biophysics. 131, 92-99.
14. Cardinault, N., Abalain, J.-H., Sairafi, B., Coudray, C., Grolier, P., Rambeau, M., Carré, J.-L., Mazur, A. and Rock, E. (2005). Lycopene but not lutein nor zeaxanthin decreases in serum and lpoproteins in age-related macular degeneration patients. Clinica Chimica Acta. 357, 34-42.
15. Chasan-Taber, L., Willett, W., Seddon, J., Stampfer, M., Rosner, B., Colditz, G. and Hankinson, S. (1999a). A prospective study of vitamin supplement intake and cataract extraction among US women. Epidemiology. 10, 679-684.
16. Chasan-Taber, L., Willett, W., Seddon, J., Stampfer, M., Rosner, B., Colditz, G., Speizer, F. and Hankinson, S. (1999b). A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. American Journal of Clinical Nutrition. 70, 509-516.
17. Chatterjee, A., Milton, R. and Thyle, S. (1982). Prevalence and etiology of cataracts in Punjab. British Journal of Ophthalmology. 66, 35-42.
18. Cho, E. Y., Stampfer, M. J., Seddon, J. M., Hung, S., Spiegelman, D., Rimm, E. B., Willett, W. C. and Hankinson, S. E. (2001). Prospective study of zinc intake and the risk of age-related macular degeneration. Annals of Epidemiology. 11, 328-336.
19. Chung, H., Harris, A., Kristinsson, J., Ciulla, T., Kageman, C. and Ritch, R. (1999). Gingko biloba extract increases ocular blood flow velocity. Journal of Ocular Pharmacology and Therapeutics. 15, 233-240.
20. 12 deficiency. Lancet. 2, 853-856.
21. Davis,K. (1991). Oxidative damage and repair: Chemical, biological and medical aspects. Pergamon Press, Oxford/New York.
22. Delcourt, C., Cristol, J. P., Tessier, F., Leger, C. L., Descomps, B. and Papoz, L. (1999). Age-related macular degeneration and antioxidant status in the POLA study. Archives of Ophthalmology. 117, 1384-1390.
23. EDCCS Group (1993). Antioxidant status and neovascular age-related macular degeneration. The Eye Disease Case Control Study Group. Archives of Ophthalmology. 111, 104-109.
24. Eisenberg, D., Davis, R., Ettner, S., Appel, S., Wilkey, S., Van Rompay, M. and Kessler, R. (1998). Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Journal of the American Medical Association. 280, 1569-1574.
25. Evans, J. (1995). Causes of blindness and partial sight in England and Wales 1990-1991. HMSO, London.
26. Evans, J. R. (2000). Ginkgo biloba extract for age-related macular degeneration. Cochrane Database of Systematic Reviews (Online: Update Software). CD001775.
27. Falsini, B., Piccardi, M., Iarossi, G., Fadda, A., Merendino, E. and Valentini, P. (2003). Influence of Short-term Antioxidant Supplementation on Macular Function in Age-Related Maculopathy. Ophthalmology. 110, 51-61.
28. Gale, C., Hall, N., Phillips, D. and Martyn, C. (2001). Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology. 108, 1992-1998.
29. Gale, C., Hall, N., Phillips, D. and Martyn, C. (2003). Lutein and Zeaxanthin Status and Risk of Age-Related Macular Degeneration. Investigative Ophthalmology and Visual Science. 44, 2461-2465.
30. Gilbert, L. (1999) 1999 HealthFocus Trend Report. HealthFocus
31. Goldberg, J., Flowerdew, G., Smith, E., Brody, J. A. and Tso, M. O. M. (1988a). Factors Associated with Age-Related Macular Degeneration - an Analysis of Data from the 1st National-Health and Nutrition Examination Survey. American Journal of Epidemiology. 128, 700-710.
32. Goldberg, J., Flowerdew, G., Tso, M. and Brody, J. (1988b). Age-related macular degeneration and cataract: are dietary antioxidants protective? American Journal of Epidemiology. 128, 904-905.
33. Gray, J. A. M. (1997). Evidence-based healthcare. How to make health body and mangement decisions. Churchill Livingstone,
34. Group TI-ACS (1991). Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. American Journal of Epidemiology. 133, 541.
35. Halliwell, B. (1991). Reactive oxygen species in living systems: source, biochemistry and role in human disease. American Journal of Medicine. 91 (Supp), 14-22.
36. Hammond, B., Wooten, B. and Snodderly, D. (1998). Preservation of visual sensitivity of older individuals: association with macular pigment density. Investigative Ophthalmology and Vision Science. 39, 397-406.
37. Hammond, B. R., Jr, Johnson, E. J., Russell, R. M., Krinsky, N. I., Yeum, K. J., Edwards, R. B. and Snodderly, D. M. (1997). Dietary modification of human macular pigment density. Investigative Ophthalmology & Visual Science. 38, 1795-1801.
38. Handelman, G., Dratz, E. and Reay, C. (1988). Carotenoids in the human macula and the whole retina. Invesigative Ophthalmology and Visual Science. 29, 850-855.
39. Handeman, G., Snodderly, D. and Adler, A. (1992). Measurement of carotenoids in human and monkey retinas. Methods in Enzymology. 213, 220.
40. Hankinson, S., Stampfer, M., Seddon, J., Colditz, J., Rosner, B., Speizer, F. and Willett, W. (1992). Nutrient intake and cataract extraction in women: a prospective study. British Medical Journal. 305, 335-339.
41. Huwiler-Muntener, K., Juni,P., Junker,C., Egger,M. (2002). Quality of Reporting Randomized Trials as a Measure of Methodologic Quality. Journal of the Americal Medical Society. 287, 2801-2804.
42. Italian-American Cataract Study Group (1991). Risk factors for age-relate cortical, nuclear, and posterior subcapsular cataract. American Journal of Epidemiology. 133, 541-553.
43. Jacques, P. and Chylack, L. (1991). Epidemiological evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. American Journal of Clinical Nutrition. 52, 1207-1211.
44. Jacques, P., Chylack, L., McGandy, R. and Hartz, S. (1988). Antioxidant status in persons with and without senile cataract. Archives of Ophthalmolgy. 106, 337-340.
45. Jacques, P. F., Taylor, A., Hankinson, S. E., Willett, W. C., Mahnken, B., Lee, Y., Vaid, K. and Lahav, M. (1997). Long-term vitamin C supplement use and prevalence of early age-related lens opacities. American Journal of Clinical Nutrition. 66, 911-916.
46. Johnson, E., Hammond, B., Yeum, K. J., Wang, X., Castaneda, C., Snodderly, D. and Russell, R. (2000). Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. American Journal of Clinical Nutrition. 71, 1555-1562.
47. Kaiser, H. J., Flammer, J., Stumpfig, D. and Hendrickson, P. (1995). Visaline in the Treatment of Age-Related Macular Degeneration - a Pilot-Study. Ophthalmologica. 209, 302-305.
48. Klein, R., Klein, B., Jensen, S. and Meuer, S. (1997). The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 104, 7-21.
49. Klein, R., Klein, B. and Linton, K. (1992). Prevalence of Age-Related Maculopathy - the Beaver Dam Eye Study. Ophthalmology. 99, 933-943.
50. Kuzniarz, M., Mitchell, P., Cumming, R. G. and Flood, V. M. (2001). Use of vitamin supplements and cataract: The Blue Mountains Eye Study. American Journal of Ophthalmology. 132, 19-26.
51. Landrum, J. T., Bone, R. A., Joa, H., Kilburn, M. D., Moore, L. L. and Sprague, K. E. (1997). A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Experimental Eye Research. 65, 57-62.
52. Lebuisson, D. A., Leroy, L. and Rigal, G. (1986). Treatment of Senile Macular Degeneration with Ginkgo Biloba Extract - a Preliminary Double-Blind, Drug Versus Placebo Study. Presse Medicale. 15, 1556-1558.
53. Leske, M., Chylack, L. and Wu, S. (1991). The lens-opacities case-control study: risk factors for cataract. Archives of Ophthalmolgy. 109, 244-251.
54. Leske, M., Wu, S., Hyman, L., Sperduto, R., Underwood, B., Chylack, L., Milton, R., Srivastava, S. and Ansari, N. (1995). Biochemical factors in the lens opacities case-control study. The Lens Opacities cae-Control Study Group. Archives of Ophthalmology. 113, 1113-1119.
55. Linner, E. (1969). The pressure-lowerinf effect of ascorbic acid in ocular hypertension. Acta Ophthalmologica. 47, 685-689.
56. Lyle, B., Mares-Perlman, J. A., Klein, B., Klein, R., Palta, M., Bowen, P. and Greger, J. (1999). Serum carotenoids and tocopherols and incidence of age-related nuclear cataract. American Journal of Clinical Nutrition. 69, 272-277.
57. Machlin, L. and Bendich, A. (1987). Free radical tissue damage: protective role of antioxidant nutrients. Faseb Journal. 1, 441-445.
58. Mares-Perlman, J., Klein, B., Klein, R. and Ritter, L. (1994). Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology. 101, 315-325.
59. Mares-Perlman, J. A., Brady, W., Klein, B., Klein, R., Haus, G., Palta, M., Ritter, L. and Shoff, S. (1995a). Diet and nuclear lens opacities. American Journal of Epidemiology. 141, 322-224.
60. Mares-Perlman, J. A., Brady, W. E., Klein, R., Klein, B. E., Bowen, P., Stacewicz-Sapuntzakis, M. and Palta, M. (1995b). Serum antioxidants and age-related macular degeneration in a population-based case-control study. Archives of Ophthalmology. 113, 1518-1523.
61. Newsome, D. A., Swartz, M., Leone, N. C., Elston, R. C. and Miller, E. (1988). Oral Zinc in Macular Degeneration. Archives of Ophthalmology. 106, 192-198.
62. Olmedilla, B., Granado, F., Blanco, I. and Vacquero, M. (2003). Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: A 2 yr double-blind, placebo-controlled pilot study. Nutrition. 119, 21-24.
63. Olmedilla, B., Granado, F., Blanco, I., Vaquero, M. and Cajigal, C. (2001). Lutein in patients with cataracts and age-related macular degeneration: a long-term supplementation study. Journal of the Science of Food and Agriculture. 81, 904-909.
64. Pease, P., Adams, A. and Nuccio, E. (1987). Optical density of human macular pigment. Vision Research. 27, 705-710.
65. Quaranta, L., Bettelli, S., Uva, M., Semeraro, F., Turano, R. and Gandolfo, E. (2003). Effect of Ginkgo biloba Extract on Preexisting Visual Field Damage in Normal Tension Glaucoma. Ophthalmology. 110, 359-364.
66. Rapp, L. M., Maple, S. S. and Choi, J. H. (2000). Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Investigative Ophthalmology & Visual Science. 41, 1200-1209.
67. Reading, V. and Weale, R. (1974). Macular pigment and chromatic aberration. Journal of the Optometric Society of America. 64, 231-238.
68. Richer, S., Stiles, W., Statkute, L., Pulido, J., Frankowski, J., Rudy, D., Pei, K., Tsipursky, M. and Nyland, J. (2004). Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 75, 216-230.
69. Robertson, J., Donner, A. and Trevithick, J. (1989). Vitamin E intake and risk for cataracts in humans. Annals of the New York Academy of Sciences. 570, 372-382.
70. 12. Glaucoma. 14, 167-170.
71. Schalch, W. 1992 Carotenoids in the retina - a review of their possible role in preventing or limiting light damage caused by light and oxygen. In: Free Radicals and Aging (Eds I. Emerit and B. Chance) Birkhauser, Verlag, Basel, 280-298.
72. Schocket, S., Esterson, J., Bradford, B., Michaelis, M. and Richards, R. (1972). Induction of cataracts in mice by exposure to oxygen. The Israel Journal of Medical Science. 8, 1596-1601.
73. Simon, J. and Hudes, E. (1999). Serum ascorbic acid and other correlates of self-reported cataract among older Americans. Journal of Clinical Epidemiology. 52, 1207-1211.
74. Smith, W., Mitchell, P., Webb, K. and Leeder, S. R. (1999). Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology. 106, 761-767.
75. Snodderly, D. M., Brown, B., Delori, F. and Auran, J. (1984). The macular pigment I. Absorbance spectra, localisation, and discrimination from other yellow pigments in primate retinas. Investigative Ophthalmological Vision Science. 25, 660-673.
76. Sommer, A. (1989). Intraocular pressure and glaucoma. American Journal of Ophthalmology. 107, 186-188.
77. Sommerburg, O., Siems, W., Hurst, J., Lewis, J., Kliger, D. and van Kuijk, F. (1999a). Lutein and zeaxanthin are associated with photoreceptors in the human retina. Current Eye Research. 19, 491-495.
78. Sommerburg, O., Siems, W., Hurst, J., Lewis, J., Kliger, D. and Van Kuijk, F. (1999b). Lutein ans zeaxanthin are associated with photoreceptors in the human retina. Current Eye Research. 19, 491-495.
79. Stur, M., Tittl, M., Reitner, A. and Meisinger, V. (1996). Oral zinc and the second eye in age-related macular degeneration. Investigative Ophthalmology & Visual Science. 37, 1225-1235.
80. Sujak, A., Gabrielska, J., Grudzinsnki, W., Borc, R., Mazurek, P. and Gruszecki, W. (1999). Lutein and Zeaxanthin as Protectors of Lipid Membranes against Oxidative Damage: The Structural Aspects. Archives of Biochemistry and Biophysics. 15, 301-307.
81. Tavani, A., Negri, E. and La Vecchia, C. (1996). Food and nutrient intake and risk of cataract. Annals of Epidemiology. 6, 41-46.
82. Taylor, H. R., Tikellis, G., Robman, L. D., McCarty, C. A. and McNeil, J. J. (2002). Vitamin E supplementation and macular degeneration: randomised controlled trial. British Medical Journal 325, 11.
83. Teikari, J. M., Laatikainen, L., Virtamo, J., Haukka, J., Rautalahti, M., Liesto, K., Albanes, D., Taylor, P. and Heinonen, O. P. (1998). Six-year supplementation with alphatocopherol and beta- carotene and age-related maculopathy. Acta Ophthalmologica Scandinavica. 76, 224-229.
84. The AREDS Research Group (2001a). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss - AREDS Report No. 9. Archives of Ophthalmology. 119, 1439-1452.
85. The AREDS Research Group (2001b). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8. Archives of Ophthalmology. 119, 1417-1436.
86. The REACT Group (2001). The Roche European American Catract Trial (REACT): A randomized clincal trial to invstigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiology. 9, 49-80.
87. Valero, M., LFletcher, A., De Stavola, B., Vioques, J. and Alepuz, V. (2001). Vitamin C Is Associated with Reduced Risk of Cataract in a Mediterranean Population. Nutritional Epidemiology. 132, 1299-1306.
88. VandenLangenberg, G. M., Mares-Perlman, J. A., Klein, R., Klein, B. E., Brady, W. E. and Palta, M. (1998). Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. American Journal of Epidemiology. 148, 204-214.
89. Varma, S. (1981). Superoxide and lens of the eye: a new theory of cataractogenesis. International Journal of Quantum Chemistry. 20, 479-484.
90. Varma, S. (1991). Scientific basis for medical therapy of cataracts by antioxidants. American Journal of Clinical Nutrition. 53, 335S-345S.
91. Varma, S., Ets, T. and Richards, R. (1977). Protection against superoxide radicals in rat lens. Ophthalmic Research. 9, 421-431.
92. Varma, S., Kumar, S. and Richards, R. (1979). Light-induced damage to oxular lens cation pump: prevention by vitamin C. Proceedings of the National Academy of Sciences of the United States of America. 76, 3504-3506.
93. Varma, S., Richards, R. and Morris, S. (1986). Ocular damage by hematoporphyrin and light. In vitro studies with lens. Lens Research. 3, 319-333.
94. Vitale, S., West, C. E., Hallfrisch, J., Alston, C., Wang, F., Moorman, C., Muller, D., Singh, V. and Taylor, H. (1993a). Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology. 4, 195-203.
95. Vitale, S., West, S. and Hallfrisch, J. (1993b). Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology. 43, 195-203.
96. West, S., Vitale, S., Hallfrisch, J., Munoz, B., Muller, D., Bressler, S. and Bressler, N. M. (1994). Are Antioxidants or Supplements Protective for Age-Related Macular Degeneration. Archives of Ophthalmology. 112, 222-227.
97. Zarbin, M. (2004). Current concepts in the pathogenesis of age-related macular degeneration. Archives of Ophthalmology. 122, 598-614.
98. Zigler, J. and Goosey, J. (1984). Singlet oxygen as a possible factor in human senile cataract development. Current Eye Research. 3, 59-65.